Drugplain

VAQTA 25 [iU]/.5mL

hepatitis A vaccine, inactivated · INJECTION, SUSPENSION · Merck Sharp & Dohme LLC

No Recall History
Plain English

Vaqta is an inactivated hepatitis A vaccine given as an injection to help protect you from hepatitis A infection. It is available over-the-counter and works by stimulating your immune system to develop immunity against the hepatitis A virus.

Key Facts

Brand Name
VAQTA
Generic Name
hepatitis A vaccine, inactivated
NDC Code (Product)
0006-4095
Manufacturer
Merck Sharp & Dohme LLC
Strength
25 [iU]/.5mL
Dosage Form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Marketing Status
Application #
BLA103606
Marketing Start
03/29/1996

Recall History

No Recall History

Frequently Asked Questions

What is VAQTA used for?

Vaqta is an inactivated hepatitis A vaccine given as an injection to help protect you from hepatitis A infection. It is available over-the-counter and works by stimulating your immune system to develop immunity against the hepatitis A virus.

Is VAQTA a controlled substance?

VAQTA is not classified as a controlled substance by the DEA.

What is the generic name for VAQTA?

The generic name for VAQTA is hepatitis A vaccine, inactivated. There are no other listed brand versions of hepatitis A vaccine, inactivated.

What is the NDC code for VAQTA 25 [iU]/.5mL?

The NDC (National Drug Code) for VAQTA 25 [iU]/.5mL is 0006-4095, listed by Merck Sharp & Dohme LLC.

Product NDC

0006-4095

Package NDC

0006-4095-02

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)